Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
It was reported recently that human fibroblasts can be reprogrammed into a pluripotent state that resembles that of human embryonic stem (hES) cells. This was achieved by ectopic expression of four genes followed by culture on mouse embryonic fibroblast (MEF) feeders under a condition favoring hES cell growth. However, the efficiency of generating human induced pluripotent stem (iPS) cells is low, especially for postnatal human fibroblasts. We started supplementing with an additional gene or bioactive molecules to increase the efficiency of generating iPS cells from human adult as well as fetal fibroblasts. We report here that adding SV40 large T antigen (T) to either set of the four reprogramming genes previously used enhanced the efficiency by 23–70-fold from both human adult and fetal fibroblasts. Discernible hES-like colonies also emerged 1–2 weeks earlier if T was added. With the improved efficiency, we succeeded in replacing MEFs with immortalized human feeder cells that we previously established for optimal hES cell growth. We further characterized individually picked hES-like colonies after expansion (up to 24 passages). The majority of them expressed various undifferentiated hES markers. Some but not all the hES-like clones can be induced to differentiate into the derivatives of the three embryonic germ layers in both teratoma formation and embryoid body (EB) formation assays. These pluripotent clones also differentiated into trophoblasts after EB formation or bone morphogenetic protein 4 induction as classic hES cells. Using this improved approach, we also generated hES-like cells from homozygous fibroblasts containing the sickle cell anemia mutation Hemoglobin Sickle. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More studies are working on enhancing the iPSC reprogramming efficiency, such as by adding SV40 large T antigen (T) by 23–70-fold from human fibroblasts [104].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [104]
In the citing paper
“Suppression of p53 by viral protein or siRNA facilitated reprograming of iPS [70, 71].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [71]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Generation of human induced pluripotent stem cells from dermal fibroblasts
Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
c-Myc Is Dispensable for Direct Reprogramming of Mouse Fibroblasts
Wernig, M., Meissner, A., Cassady, J. P., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.12.001 · Cited by 628
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 612
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation
Ahuja, D., Sáenz-Robles, M. T., & Pipas, J. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209046 · Cited by 557
Dravid, G., Ye, Z., Hammond, H., Chen, G., Pyle, A., Donovan, P., Yu, X., & Cheng, L. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0034 · Cited by 342
Self-citationHuman Adult Marrow Cells Support Prolonged Expansion of Human Embryonic Stem Cells in Culture
Cheng, L., Hammond, H., Ye, Z., Zhan, X., & Dravid, G. (2003) · STEM CELLS · doi:10.1634/stemcells.21-2-131 · Cited by 331
Self-citationTaranger, C. K., Noer, A., Sørensen, A. L., Håkelien, A.-M., Boquest, A. C., & Collas, P. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0572 · Cited by 286
Generation of Induced Pluripotent Stem Cells in the Absence of Drug Selection
Blelloch, R., Venere, M., Yen, J., & Ramalho-Santos, M. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.008 · Cited by 283
Frequency and Stability of Chromosomal Integration of Adenovirus Vectors
Harui, A., Suzuki, S., Kochanek, S., & Mitani, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6141-6146.1999 · Cited by 221
Epigenetic Reprogramming of OCT4 and NANOG Regulatory Regions by Embryonal Carcinoma Cell Extract
Freberg, C. T., Dahl, J. A., Timoskainen, S., & Collas, P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0029 · Cited by 198
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192
Self-citationCheng, L., & Kelly, T. J. (1989) · Cell · doi:10.1016/0092-8674(89)90037-8 · Cited by 174
Self-citationFunctional antigen-presenting leucocytes derived from human embryonic stem cells in vitro
Zhan, X., Dravid, G., Ye, Z., Hammond, H., Shamblott, M., Gearhart, J., & Cheng, L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16629-4 · Cited by 160
Self-citationYu, Y., & Alwine, J. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3731-3738.2002 · Cited by 147
Isolation and characterization of a multipotent clone of human embryonal carcinoma cells
Pera, M. F., Cooper, S., Mills, J., & Parrington, J. M. (1989) · Differentiation · doi:10.1111/j.1432-0436.1989.tb00602.x · Cited by 131
Bocchetta, M., Eliasz, S., Marco, M. A. D., Rudzinski, J., Zhang, L., & Carbone, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5203 · Cited by 105
Cai, L., Ye, Z., Zhou, B. Y., Mali, P., Zhou, C., & Cheng, L. (2007) · Cell Research · doi:10.1038/sj.cr.7310138 · Cited by 98
Self-citationZhou, B. Y., Ye, Z., Chen, G., Gao, Z. P., Zhang, Y. A., & Cheng, L. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0128 · Cited by 70
Self-citationChen, G., Ye, Z., Yu, X., Zou, J., Mali, P., Brodsky, R. A., & Cheng, L. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.02.004 · Cited by 50
Self-citationYu, Y., & Alwine, J. C. (2008) · Journal of Virology · doi:10.1128/jvi.02365-07 · Cited by 37
Han, Z., Zhong, L., Maina, N., Hu, Z., Li, X., Chouthai, N. S., Bischof, D., Weigel-Van Aken, K. A., Slayton, W. B., Yoder, M. C., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.161 · Cited by 35
Durán, C., Talley, P. J., Walsh, J., Pigott, C., Morton, I. E., & Andrews, P. W. (2001) · International Journal of Cancer · doi:10.1002/ijc.1355 · Cited by 35
Initiation of SV40 DNA Replication: Mechanism and ControlPreprint
Erdile, L. F., Collins, K. L., Russo, A. A., Simancek, P., Small, D., Umbricht, C. B., Virshup, D. M., Cheng, L., Randall, S. K., Weinberg, D., et al. (1991) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1991.056.01.037 · Cited by 35
Self-citationLentiviral Gene Transduction of Mouse and Human Stem Cells
Ye, Z., Yu, X., & Cheng, L. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-182-6_17 · Cited by 33
Self-citationMahale, A. M., Khan, Z., Igarashi, M., Nanjangud, G. J., Qiao, R., Yao, S., Lee, S. W., & Aaronson, S. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3021 · Cited by 22
Culture of Human Embryonic Stem Cells on Human and Mouse Feeder Cells
Dravid, G. G., Hammond, H., & Cheng, L. (2006) · Humana Press eBooks · doi:10.1385/1-59745-046-4:91 · Cited by 18
Self-citation
Cited by
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889
“In agreement, some reprogrammed lines fail to differentiate and form undifferentiated tumours on injection into immunodeficient mic”
BackgroundImmortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 836
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
“For instance, overexpression of SV40 large T antigen (Mali et al. 2008; Park et al. 2008c) or Rem2 GTPase (Edel et al.”
BackgroundOkita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A., Goshima, N., & Yamanaka, S. (2013) · Stem Cells · doi:10.1002/stem.1293 · Cited by 749
Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem Cells
Zou, J., Maeder, M. L., Mali, P., Pruett-Miller, S. M., Thibodeau-Beganny, S., Chou, B.-K., Chen, G., Ye, Z., Park, I.-H., Daley, G. Q., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.023 · Cited by 509
Self-citation
Metadata
- Authors
- Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Cheng, Linzhao
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-29
- Volume
- 26
- Issue
- 8
- Pages
- 1998-2005
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2061824613
- Cited by
- 291
- References
- 32
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 14 · 2015: 19 · 2014: 19 · 2013: 20 · 2012: 30
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl073781-10)
- National Heart, Lung, and Blood Institute (R01 HL-073781)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, fibroblast reprogramming, SV40 large T antigen, reprogramming efficiency, human embryonic stem cells, teratoma formation, embryoid body differentiation, trophoblast differentiation, sickle cell disease, stem cell markers
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Differentiation, Cell Line, Culture Media, Fibroblasts, Homozygote, Humans, Karyotyping, Mutation, Lentivirus, Transgenes, Pluripotent Stem Cells, Embryo Culture Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.